MODIFICATION OF THE MYCOBACTERIUM-BOVIS EXTRACELLULAR PROTEIN MPB70 WITH FLUORESCEIN FOR RAPID DETECTION OF SPECIFIC SERUM ANTIBODIES BY FLUORESCENCE POLARIZATION
M. Lin et al., MODIFICATION OF THE MYCOBACTERIUM-BOVIS EXTRACELLULAR PROTEIN MPB70 WITH FLUORESCEIN FOR RAPID DETECTION OF SPECIFIC SERUM ANTIBODIES BY FLUORESCENCE POLARIZATION, Clinical and diagnostic laboratory immunology, 3(4), 1996, pp. 438-443
The principle of fluorescence polarization described by Perrin (F. Per
rin, J. Phys, Radium 7:390-401, 1926) was applied to the development o
f a novel assay that used fluorescein-labeled Mycobacterium bovis secr
etory protein MPB70 for rapid detection of anti-MPB70 antibodies in se
lected sera from three M. bovis-infected species (elk, Ilama, and biso
n). Labeling of purified MPB70 with fluorescein isothiocyanate resulte
d in the incorporation of 0.96 +/- 0.08 (mean +/- standard deviation;
n = 3) fluorescein group per MPB70 molecule. The labeled protein fluor
esced strongly with an emission maximum at 518 nm when excited with li
ght of a wavelength near 493 nm, and its immunoreactivity with anti-MP
B70 monoclonal antibody 4C3/17 was not altered by modification with fl
uorescein. The fluorescence polarization assay protocol was optimized
for analysis of serum samples by incorporating into the assay buffer 0
.05% lithium dodecyl sulfate, which prevents the occurrence of some no
nspecific interactions. Sera from M. bovis-infected animals, selected
on the basis of exhibiting the presence of anti-MPB70 antibodies, as d
etected by enzyme-linked immunosorbent assay (ELISA), reacted with flu
orescein-labeled MPB70, resulting in an increase in polarization of up
to 330 milli-polarization units, in contrast to the values for noninf
ected sera (167 to 178 mP), which were close to that obtained in the a
bsence of specific antibodies (164.7 +/- 3.3 mP; n = 6). These results
demonstrated the feasibility of using fluorescein-labeled MPB70 to de
tect anti-MPB70 antibodies by fluorescence polarization and suggested
that the assay described here can be an alternative to ELISA or other
antibody assay systems. The advantages of this original methodology an
d its general applicability to the diagnosis of infectious diseases ar
e discussed.